Microwave assistant synthesis of trans-4-nitrostilbene derivatives in solvent free condition

A general method for the synthesis of trans-4-nitrostilbenes has been developed. The trans-4-nitrostilbene could be synthesized in good yields under microwave irradiation within 10 min through Perkin reaction by using 4-nitrophenylacetic acid, benzaldehydes and pyrrolidine

TransPrompt v2: A Transferable Prompting Framework for Cross-task Text Classification

Text classification is one of the most imperative tasks in natural language processing (NLP). Recent advances with pre-trained language models (PLMs) have shown remarkable success on this task. However, the satisfying results obtained by PLMs heavily depend on the large amounts of task-specific labeled data, which may not be feasible in many application scenarios due to data access and privacy constraints. The recently-proposed prompt-based fine-tuning paradigm improves the performance of PLMs for few-shot text classification with task-specific templates. Yet, it is unclear how the prompting knowledge can be transferred across tasks, for the purpose of mutual reinforcement. We propose TransPrompt v2, a novel transferable prompting framework for few-shot learning across similar or distant text classification tasks. For learning across similar tasks, we employ a multi-task meta-knowledge acquisition (MMA) procedure to train a meta-learner that captures the cross-task transferable knowledge. For learning across distant tasks, we further inject the task type descriptions into the prompt, and capture the intra-type and inter-type prompt embeddings among multiple distant tasks. Additionally, two de-biasing techniques are further designed to make the trained meta-learner more task-agnostic and unbiased towards any tasks. After that, the meta-learner can be adapted to each specific task with better parameters initialization. Extensive experiments show that TransPrompt v2 outperforms single-task and cross-task strong baselines over multiple NLP tasks and datasets. We further show that the meta-learner can effectively improve the performance of PLMs on previously unseen tasks. In addition, TransPrompt v2 also outperforms strong fine-tuning baselines when learning with full training sets

Photoelastic plasmonic metasurfaces with ultra-large near infrared spectral tuning

Metasurfaces, consisting of artificially fabricated sub-wavelength meta-atoms with pre-designable electromagnetic properties, provide novel opportunities to a variety of applications such as light detectors/sensors, local field imaging and optical displays. Currently, the tuning of most metasurfaces requires redesigning and reproducing the entire structure, rendering them ineligible for post-fabrication shape-morphing or spectral reconfigurability. Here, we report a photoelastic metasurface with an all-optical and reversible resonance tuning in the near infrared range. The photoelastic metasurface consists of hexagonal gold nanoarrays deposited on a deformable substrate made of a liquid crystalline network. Upon photo-actuation, the substrate deforms, causing the lattice to change and, as a result, the plasmon resonance to shift. The centre wavelength of the plasmon resonance exhibits an ultra-large spectral tuning of over 245 nm, from 1490 to 1245 nm, while the anisotropic deformability also endows light-switchable sensitivity in probing polarization. The proposed concept establishes a light-controlled soft platform that is of great potential for tunable/reconfigurable photonic devices, such as nano-filters, -couplers, -holograms, and displays with structural colors.publishedVersionPeer reviewe

Efficacy of hyperbaric oxygen therapy as an adjunct therapy in the treatment of sleep disorders among patients with Parkinson’s disease: a meta-analysis

ObjectiveTo systematically evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunct therapy for treating sleep disorders in patients with Parkinson’s disease (PD).MethodsWe conducted comprehensive searches in eight databases from inception through September 2023, including PubMed, Cochrane Library, Embase, Web of Science, SinoMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Periodical Database (VIP), and Wanfang Database. The objective was to identify randomized controlled trials (RCTs) evaluating HBOT’s effectiveness in alleviating sleep disorder symptoms in PD patients as an adjunct therapy. Literature screening and data extraction were independently executed by the authors. Meta-analyses were performed using Review Manager 5.3 software, and publication bias and sensitivity analyses were assessed using Stata 17.0 software.ResultsSeven RCTs involving 461 participants were included. The findings revealed that the addition of HBOT significantly enhanced sleep efficiency (MD = 15.26, 95% CI [10.89, 19.63], p < 0.00001), increased time in bed (MD = 69.65, 95% CI [43.01, 96.30], p < 0.00001), total sleep time (MD = 75.87, 95% CI [25.42, 126.31], p = 0.003), slow-wave sleep (SWS) time (MD = 6.14, 95% CI [3.95, 8.34], p < 0.00001), and rapid eye movement sleep (REM) time (MD = 4.07, 95% CI [2.05, 6.08], p < 0.0001), and reduced awakening frequency (MD = −11.55, 95% CI [−15.42, −7.68], p < 0.00001) and sleep latency (MD = −6.60, 95% CI [−9.43, −3.89], p < 0.00001). Additionally, significant improvements were observed in the Pittsburgh Sleep Quality Index (PSQI) (MD = −2.52, 95% CI [−2.85, −2.18], p < 0.00001), Epworth Sleepiness Scale (ESS) (MD = −2.90, 95% CI [−3.34, −2.47], p < 0.00001), Unified Parkinson’s Disease Rating Scale Part III (UPDRS III) (MD = −1.32, 95% CI [−2.16, −0.47], p = 0.002), and Hoehn and Yahr grading (H-Y grading) (MD = −0.15, 95% CI [−0.28, −0.01], p = 0.03).ConclusionThe current meta-analysis supports the efficacy of HBOT as an adjunct therapy in managing sleep disorders in PD patients. It is recommended for PD patients experiencing sleep disturbances.Systematic review registration:https://www.crd.york.ac.uk/, identifier: CRD42023462201

Molecular footprints of domestication and improvement in soybean revealed by whole genome re-sequencing

BACKGROUND: Artificial selection played an important role in the origin of modern Glycine max cultivars from the wild soybean Glycine soja. To elucidate the consequences of artificial selection accompanying the domestication and modern improvement of soybean, 25 new and 30 published whole-genome re-sequencing accessions, which represent wild, domesticated landrace, and Chinese elite soybean populations were analyzed. RESULTS: A total of 5,102,244 single nucleotide polymorphisms (SNPs) and 707,969 insertion/deletions were identified. Among the SNPs detected, 25.5% were not described previously. We found that artificial selection during domestication led to more pronounced reduction in the genetic diversity of soybean than the switch from landraces to elite cultivars. Only a small proportion (2.99%) of the whole genomic regions appear to be affected by artificial selection for preferred agricultural traits. The selection regions were not distributed randomly or uniformly throughout the genome. Instead, clusters of selection hotspots in certain genomic regions were observed. Moreover, a set of candidate genes (4.38% of the total annotated genes) significantly affected by selection underlying soybean domestication and genetic improvement were identified. CONCLUSIONS: Given the uniqueness of the soybean germplasm sequenced, this study drew a clear picture of human-mediated evolution of the soybean genomes. The genomic resources and information provided by this study would also facilitate the discovery of genes/loci underlying agronomically important traits

Upregulation of CCNB2 and Its Perspective Mechanisms in Cerebral Ischemic Stroke and All Subtypes of Lung Cancer: A Comprehensive Study

Cyclin B2 (CCNB2) belongs to type B cell cycle family protein, which is located on chromosome 15q22, and it binds to cyclin-dependent kinases (CDKs) to regulate their activities. In this study, 103 high-throughput datasets related to all subtypes of lung cancer (LC) and cerebral ischemic stroke (CIS) with the data of CCNB2 expression were collected. The analysis of standard mean deviation (SMD) and summary receiver operating characteristic (SROC) reflecting expression status demonstrated significant up-regulation of CCNB2 in LC and CIS (Lung adenocarcinoma: SMD = 1.40, 95%CI [0.98–1.83], SROC = 0.92, 95%CI [0.89–0.94]. Lung squamous cell carcinoma: SMD = 2.56, 95%CI [1.64–3.48]. SROC = 0.97, 95%CI [0.95–0.98]. Lung small cell carcinoma: SMD = 3.01, 95%CI [2.01–4.01]. SROC = 0.98, 95%CI [0.97–0.99]. CIS: SMD = 0.29, 95%CI [0.05–0.53], SROC = 0.68, 95%CI [0.63–0.71]). Simultaneously, protein-protein interaction (PPI) analysis indicated that CCNB2 is the hub molecule of crossed high-expressed genes in CIS and LC. Through Multiscale embedded gene co-expression network analysis (MEGENA), a gene module of CIS including 76 genes was obtained and function enrichment analysis of the CCNB2 module genes implied that CCNB2 may participate in the processes in the formation of CIS and tissue damage caused by CIS, such as “cell cycle,” “protein kinase activity,” and “glycosphingolipid biosynthesis.” Afterward, via single-cell RNA-seq analysis, CCNB2 was found up-regulated on GABAergic neurons in brain organoids as well as T cells expressing proliferative molecules in LUAD. Concurrently, the expression of CCNB2 distributed similarly to TOP2A as a module marker of cell proliferation in cell cluster. These findings can help in the field of the pathogenesis of LC-related CIS and neuron repair after CIS damage

Effect of coexisting adenomyosis on tumour characteristics and prognosis of endometrial cancer: A systematic review and meta-analysis

To compare clinicopathological features and survival outcomes in patients with endometrial cancer, with and without associated adenomyosis. PubMed, Embase and Scopus databases were systematically searched for relevant observational studies. The pooled effect sizes were reported as either hazards ratio (HR) for survival-related outcomes or as odds ratio (OR) for other categorical outcomes. Weighted mean difference (WMD) was reported for continuous outcomes. All the analyses used the random effects model. A total of 21 studies (N = 46,420) were included. Compared to endometrial cancer patients without adenomyosis, patients with associated adenomyosis had improved overall 5-year survival (OS) (HR 0.62, 95% CI: 0.50, 0.79) and disease-free survival (DFS) (HR 0.60, 95% CI: 0.44, 0.82). Disease-specific survival was statistically similar in patients with and without adenomyosis (HR 0.60, 95% CI: 0.35, 1.05). Among patients with adenomyosis, the risk of having an advanced tumour grade (Grade 2 or 3) was lower (OR 0.51, 95% CI: 0.42, 0.62) and a risk of having International Federation of Gynaecology and Obstetrics (FIGO) stage I or II was higher (OR 2.23, 95% CI: 1.65, 3.01). Patients with adenomyosis had lower risk of tumour invasion of adnexa, cervical stromal invasion, deep myometrial involvement (DMI), lympho-vascular space invasion (LVSI) and peritoneal invasion. Presence of adenomyosis in patients with endometrial cancer is associated with favourable tumour characteristics and may improve the survival

Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies

Abstract Background Though a number of studies have been conducted to explore the association between myeloperoxidase (MPO)-463G > A polymorphism and cancer risk, the results remain inconsistent. Therefore, we performed a meta-analysis to derive a more systematic estimation of this relationship. Method Relevant studies were searched by PubMed, EMBASE, CNKI, Google Scholar, Ovid, and Cochrane library prior to December 2015. The strength of the association between MPO-463G > A polymorphism and cancer risk was estimated by odds ratios (OR) with 95% confidence interval (95%CI). Cumulative analysis was used to evaluate the stability of results through time. Results The current analysis consisted of 16,858 cases and 21,756 controls from 60 studies. Pooled results showed that MPO-463G > A polymorphism were associated with the overall decreased cancer susceptibility in all the genetic models included in this study (additive model: OR = 0.84, 95%CI = 0.76–0.94; allele genetic model: OR = 0.90, 95%CI = 0.840–0.954; recessive genetic model: OR = 0.89, 95%CI = 0.83–0.95). However, in the stratified analysis of cancer type, the significant results were only found in lung cancer (dominant model: OR = 0.93, 95%CI = 0.87–0.99) and digestive system cancer groups (dominant model: OR = 0.67 0.53–0.84; allele frequency model = 0.71, 95%CI = 0.57–0.87), but not in the blood system cancer or breast cancer group. When we further stratified the digestive system cancer group into digestive tract and digestive gland cancer groups, results showed a significant association between allele A of MPO-463G > A and digestive gland cancer in all the genetic models (allele frequency model: OR = 0.63, 95%CI = 0.40–0.99; additive model: OR = 0.41, 95%CI = 0.23–0.73; recessive model: OR = 0.51, 95%CI = 0.29–0.89; dominant model: OR = 0.58, 95%CI = 0.35–0.96), digestive tract cancers in allele frequency model (OR = 0.75, 95%CI = 0.59–0.95), and dominant model (OR = 0.72, 95%CI = 0.56–0.92). When stratified by ethnicity, results demonstrated that the genotype A might be a protect factor for both Caucasians and Asians. In group analysis according to source of controls, significant results were found in population from hospital in all the genetic models. In cumulative analysis, result of allele contrast showed a declining trend and increasingly narrower 95% overall, while the inclination toward non-significant association with lung cancer risk. Conclusions This meta-analysis suggested that MPO-463G > A polymorphism was associated with the overall reduced cancer susceptibility significantly. It might be a more reliable predictor of digestive system cancer instead of lung cancer, blood system cancer, and breast cancer. In cumulative analysis, the stable trend indicated that evidence was sufficient to show the association between MPO-463G > A polymorphism and cancer risk

Localization of immunodominant linear B-cell epitopes of Vibrio mimicus outer membrane protein U (OmpU)

Outer membrane protein U (OmpU), an adhesion protein of Vibrio mimicus, is a good antigen, but its epitopes are still unclear. In order to locate the epitopes of OmpU protein, epitope prediction was performed using the amino acid sequence of OmpU protein of V. mimicus HX4 strain that was isolated from the diseased crass carp in Anhui province of China. The secondary structure, flexible regions, hydrophilicity, surface accessibility and antigenic index of the protein were analyzed using the DNAStar Protean program, and seven potential epitopes were screened. To verify the prediction, the potential epitope peptides were artificially synthesized and detected by peptide-enzyme linked immunosorbent assay (ELISA). The results show that the potential epitope peptides at amino acid positions 25 to 33, 90 to 98, 117 to 126, 173 to 180, 183 to 195, 211 to 218 and 239 to 250 were indeed immunodominant linear B-cell epitopes of the OmpU protein. Among them, the epitopes at amino acid positions 25 to 33, 90 to 98 and 239 to 250 were entirely exposed on the surface of the 3D structure model of OmpU protein, and they had a stronger immunoreactivity than others that were partially embedded inside the protein molecule.Keywords: Vibrio mimicus, outer membrane protein U (ompU), linear B-cell epitope, localization, enzyme-linked immunosorbent assa